Search clinical trials for: Retinal Vein Occlusive disease

Total 384489 results

Novartis Pharmaceuticals

Completed

Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema

Diabetic Macular Edema

Germany, Turkey, United States, Spain, Puerto Rico
Benskin, Linda, PhD, RN, SRN (Ghana), CWCN, CWS...
The University of The West Indies; University Hospital of the West Indies; Wound... and other collaborators

Completed

Test of the Safety, Effectiveness, & Acceptability of An Improvised Dressing for Sickle Cell Leg Ulcers in the Tropics (SCLUJamaica)

Sickle Cell Leg Ulcer

Jamaica
Paracelsus Medical University
MedAlliance Swiss Medical Technology

Active, not recruiting

The SIR-POBA Bypass Trial

Peripheral Arterial Occlusive Disease | Claudication, Intermittent | Bypass Complication | Femoropopliteal Artery Occlusion | Femoropopliteal Stenosis | Critical Limb-Threatening Ischemia

Austria
Hôpital NOVO

Completed

The Future of Revascularization Using a Bioprotec Graft (REVATEC)

Peripheral Artery Disease

France
The University of The West Indies

Completed

Correlation of Microvascular Ophthalmic Disease With Macrovascular Coronary Artery Disease in Trinidad (EYE-MI TNT)

Retinal Disease

Trinidad and Tobago
University of Nebraska

Withdrawn

Lower Extremity Regional Anesthesia and Infrainguinal Bypass Grafting

Peripheral Vascular Disease

United States
GE Healthcare
Pharmaceutical Product Development, LLC

Completed

An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)

Coronary Artery Disease (CAD)

United States, Germany, Switzerland, Canada, Netherlands, France, Finland
Centre Hospitalier Intercommunal Creteil
Bayer; Association Clinique Thérapeutique Infantile du val de Marne

Completed

Ultra-wide Fluorescein Angiography in Patients With Central Retinal Vein Occlusion Treated by Afilbercept (HERMES)

Retinal Vein Occlusion

France
Novartis Pharmaceuticals

Completed

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients

Diabetic Macular Edema | Macular Edema | Retinal Vein Occlusion | Neovascular Age-related Macular Degeneration

United States, Puerto Rico
Vascular Graft Solutions Ltd.
International Center for Health Outcomes and Innovation Research

Active, not recruiting

VEST Venous Graft External Support Pivotal Study (VEST Pivotal)

Coronary Artery Disease

United States, Canada
University of Iowa

Completed

Cool vs Room-temperature Artificial Tears

Eye Pain | Ocular Surface Disease | Cystoid Macular Edema | Central Retinal Vein Occlusion With Macular Edema | Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis) | Exudative Age-Related Macular Degeneration, Unspecified Eye | Dry Eye Sensation

United States
Vascular Graft Solutions Ltd.

Suspended

FRAME, External Support for Lower Limb Autologous Grafts

Peripheral Arterial Disease | Peripheral Artery Disease

United States
Allergan

Completed

Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China

Macular Edema | Retinal Vein Occlusion

China
Universitaire Ziekenhuizen KU Leuven

Withdrawn

Surgical Stabilizer Assisted RVC With rtPA for CRVO

Central Retinal Vein Occlusion

Belgium
PQ Bypass, Inc.

Active, not recruiting

The DETOUR2 Clinical Study

Peripheral Arterial Disease

United States, Germany, Latvia
AbbVie

Completed

A Study to Evaluate an Updated Dexamethasone Intravitreal (Into the Eye) Applicator in Adult Participants With Macular Edema Due to Diseases of the Retina

Macular Edema

United States
Retina Vitreous Associates of Florida
Ocular Therapeutix, Inc.

Terminated

Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections (DETeR)

Diabetic Macular Edema | Retinal Vein Occlusion | Neovascular Age-related Macular Degeneration

United States
Xinhua Hospital, Shanghai Jiao Tong University...

Completed

Changes of Visual Field Defects After IAT for CRAO

Visual Field | Central Retinal Artery Occlusion | Intra-arterial Thrombolysis

China
Bayer

Completed

Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice (MAIA)

Retinal Disease

Mexico
University Hospital Inselspital, Berne

Terminated

Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina

Age-related Macular Degeneration | Macular Edema | Retinal Vein Occlusion | Central Serous Chorioretinopathy | Retinal Neovascularization

Switzerland
Novartis Pharmaceuticals

Terminated

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion (RAPTOR)

Branch Retinal Vein Occlusion

China, Austria, Czechia, Russian Federation, Taiwan, United Kingdom, Canada, Japan, United States, France, Israel, Germany, Italy, Hong Kong, Spain, Denmark, Slovakia, Puerto Rico, Switzerland
Novartis Pharmaceuticals

Terminated

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion (RAVEN)

Central Retinal Vein Occlusion

China, Czechia, Germany, Russian Federation, Turkey, United States, Australia, Canada, Spain, United Kingdom, Thailand, Israel, Netherlands, Italy, Hungary, France, Greece, Puerto Rico, Malaysia, Japan
Ra Medical Systems

Completed

A Prospective, Multicenter Atherectomy Study Showing Luminal Gain in Subjects With Peripheral Vascular Blockages

Peripheral Arterial Disease

United States
Beijing Hospital

Completed

Combination of Intravitreal Ranibizumab With or Without Macular Laser Photocoagulation for ME Secondary to BRVO

Branch Retinal Vein Occlusion | Ranibizumab | Laser Photocoagulation

China
Novartis Pharmaceuticals

Completed

Analysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retinal Vasculitis and/or Retinal Vascular Occlusion

Intraocular Inflammation | Retinal Vascular Occlusion

Switzerland
Bayer
Regeneron Pharmaceuticals

Completed

A Study to Evaluate the Effectiveness of Intravitreal Aflibercept in Patients With Diabetic Macular Edema and/or Macular Edema Secondary to Retinal Vein Occlusion, Which Either Have or Have Not Been Pretreated for Their Disease (AURIGA)

Macular Edema

Germany, Italy, Russian Federation, Taiwan, China, Egypt, France, Kuwait, Lebanon, Saudi Arabia, United Arab Emirates
Basecamp Vascular

Completed

ACtive Catheterization for EndovaScular TreatmentS (ACCESS)

Carotid Stenosis | Unruptured Intracranial Aneurysm | Arteriovenous Cerebral Malformations

France
University of California, Irvine
Beckman Laser Institute University of California Irvine

Completed

A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging

Glaucoma | Age-Related Macular Degeneration | Diabetic Retinopathy | Central Retinal Vein Occlusion | Branch Retinal Vein Occlusion

United States
Hayatabad Medical Complex

Completed

Comparison of Intravitreal Anti-VEGF Versus Combination Therapy in Central Retinal Vein Occlusion (CRVO)

Central Retinal Vein Occlusion With Macular Edema

Pakistan
University of California, San Francisco
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Endothelial Function and Vein Graft Remodeling (EFVGR)

Cardiovascular Disease | Peripheral Arterial Disease

United States
Cardio Med Medical Center
University of Targu Mures, Romania; University Hospital of Targu Mures, Romania

Completed

Systemic, Pancoronary and Local Coronary Vulnerability (VIP)

Acute Coronary Syndrome | Coronary Stenosis | Acute Myocardial Infarction | Atheromatous Plaques | Non-ST Elevation Myocardial Infarction (nSTEMI) | Atheroscleroses, Coronary

Romania
VA Office of Research and Development

Completed

Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty (DIVA)

Saphenous Vein Graft Atherosclerosis

United States
Chengdu Kanghong Biotech Co., Ltd.

Completed

Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion (BRAVE)

Macular Edema | Branch Retinal Vein Occlusion

China
Chengdu Kanghong Biotech Co., Ltd.

Completed

Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion (CRAVE)

Central Retinal Vein Occlusion | Macular Edema

China
VentureMed Group Inc.

Completed

FLEX Arteriovenous Access Registry

Peripheral Artery Disease | Arteriovenous Fistula Stenosis | Arteriovenous Graft Stenosis

United States
Austin Health

Active, not recruiting

Radial Artery Patency and Clinical Outcomes Trial (RAPCO)

Coronary Artery Disease | Atherosclerosis

Australia
Al-Azhar University

Completed

Formulated PSTA Injection Versus PATA Alone in the Management of Macular Edema Secondary to Non-ischemic Retinal Vein Occlusions

Macula Edema

Egypt
iRenix Medical, Inc.

Terminated

EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN) (CLEAN)

Diabetic Macular Edema | Branch Retinal Vein Occlusion | Glaucoma/Closed Angle Glaucoma

United States
Al-Azhar University

Completed

Efficacy of Formulated Posterior Sub Tenon Triamcinolone in Macular Edema Secondary to Non-Ischemic Retinal Vein Occlusions

Retinal Vein Occlusion

Egypt
Odense University Hospital
Zealand University Hospital; Queen's University, Belfast; Synoptik-Fonden; AP Moeller... and other collaborators

Completed

Navigated Laser In Branch Retinal Vein Occlusion Study (NIRVANA)

Macular Edema | Branch Retinal Vein Occlusion

Denmark
Duke University
Optovue

Terminated

SD-OCT Angiography

Diabetic Retinopathy | Age-related Macular Degeneration | Diabetic Macular Edema | Retinal Vein Occlusion | Neovascular Age-related Macular Degeneration

United States
Novartis Pharmaceuticals

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema

Diabetic Macular Edema | Macular Edema | Neovascular Age-related Macular Degeneration | Retinal Vein Occlusions

Puerto Rico, United States
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Completed

Liver Stiffness Measurement Predicts VOD/SOS Development (ELASTOVOD ITALIAN MULTICENTRIC STUDY) (ELASTOVOD)

Stem Cell Transplant Complications | Sinusoidal Obstruction Syndrome | Veno Occlusive Disease, Hepatic

Italy
Fondation Ophtalmologique Adolphe de Rothschild

Completed

Study of Arterial Recanalization of the Central Retinal Artery Occlusions (RECANAL)

Central Retinal Artery Occlusion

France
Pfizer

Completed

Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML

Pharmacokinetics | Safety | ECG

Canada, Spain, United States, Hungary, Poland, United Kingdom
Shahid Beheshti University of Medical Sciences

Active, not recruiting

Comparison of Combined Intravitreal Bevacizumab and Oral Acetazolamide Versus Intravitreal Bevacizumab Alone for the Treatment of Macular Edema Secondary to Retinal Vein Occlusions

Macular Edema

Iran, Islamic Republic of
Fondation Ophtalmologique Adolphe de Rothschild

Completed

Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents (COVIDIV)

Diabetic Macular Edema | Retinal Vein Occlusion | Age Related Macular Degeneration

France
Jazz Pharmaceuticals

Completed

Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients

Veno-occlusive Disease

United States, Spain, Belgium, Australia, Italy, Israel, Japan, Korea, Republic of, France, Canada, United Kingdom, Germany, New Zealand, Turkey
Aerie Pharmaceuticals

Completed

Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)

Macular Edema

United States
National Eye Institute (NEI)

Completed

Minocycline to Treat Branch Retinal Vein Occlusion

Retinal Vein Occlusion

United States, United Kingdom

Search clinical trials for: Retinal Vein Occlusive disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations